Biohaven’s ambitious Nurtec ODT marketing strategy pays dividends with doctors in migraine market: analyst bbulik Tue, 09/14/2021 – 11:33 More: Biohaven's ambitious Nurtec ODT marketing strategy pays dividends with doctors in migraine market: analyst Source: fierce
read moreAfter regulatory nods, Johnson & Johnson says latest Ebola vaccine data could support prophylactic use kdunleavy Tue, 09/14/2021 – 09:52 More: After regulatory nods, Johnson & Johnson says latest Ebola vaccine data could support prophylactic use Source: fierce
read moreEmergent, after J&J woes, inks $90M deal to help produce Providence Therapeutics’ mRNA COVID-19 vaccine jkeenan Tue, 09/14/2021 – 09:42 More: Emergent, after J&J woes, inks M deal to help produce Providence Therapeutics' mRNA COVID-19 vaccine Source: fierce
read moreTakeda eyes vaccine business growth amid COVID-19 partnerships and dengue progress, CEO says aliu Tue, 09/14/2021 – 09:42 More: Takeda eyes vaccine business growth amid COVID-19 partnerships and dengue progress, CEO says Source: fierce
read morePlatform launched in a bid to help life sciences companies address the insights gap More: Within3 launches new insights management platform Source: News
read morePhase Ib trial is evaluating the potential benefit of low-dose psilocybin as a treatment for SUNHA More: First patient receives low-dose psilocybin in rare headache disorder trial Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals